Global Cervical Cancer Diagnostic Tests Market 2014-2018

子宮頸癌(Cervical Cancer)診断検査の世界市場

◆タイトル:Global Cervical Cancer Diagnostic Tests Market 2014-2018
◆商品コード:IRTNTR4839
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年12月17日
◆ページ数:103
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Five UserUSD3,300 ⇒換算¥372,900見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、子宮頸癌(Cervical Cancer)診断検査機器の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、子宮頸癌(Cervical Cancer)診断検査機器の世界市場規模及び予測、種類別分析、技術別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Cervical Cancer Diagnostic Tests
Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy and biopsy are further utilized to confirm the diagnosis. After the positive diagnosis, the patient is further subjected to imaging tests that are used to establish the grade of cancer.

TechNavio’s analysts forecast the Global Cervical Cancer Diagnostic Tests market to grow at a CAGR of 10.89 percent over the period 2013-2018.

[Covered in this Report]
The report covers the present scenario and the growth prospects of the Global Cervical Cancer Diagnostic Tests market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following diagnostic test kits and instruments used to diagnose cervical cancer:
• Pap Smear Test
• HPV Testing
• Colposcopy
• Biopsy

In addition, the report includes the type of method used to identify cervical cancer:
• Molecular method
• Cytopathological method
• Physical method

Technological types used in cervical cancer identification are also discussed in this report:
• ELISA
• FISH
• NASBA
• PCR
• Staining & Microscopy
• Optical Imaging
TechNavio’s report, the Global Cervical Cancer Diagnostic Tests Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cervical Cancer Diagnostic Tests market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Abbott Laboratories
• Becton Dickinson
• Hologic
• Qiagen
• Quest Diagnostics
• Roche Diagnostics

[Other Prominent Vendors]
• Anthera Pharmaceuticals
• Arbor Vita
• Autogenomics
• Biolight Meditech
• BioMerieux
• Biovantra
• Cancer Genetics
• Cervia Diagnostics
• Centrel
• Cooper Surgical
• Cytoimmun
• DySIS Medical
• Edan
• Femasys
• Greiner Bio One
• Guided Therapeutics
• Incell dx
• Innogenetics
• Kernel Medical
• Lutech Industries
• Medgyn
• Micromedic Technologies
• Norchip
• Olympus Medical
• OncoHealth Corp
• Optomic
• Optopol Technology
• Shenzhen Goldcare Meditech
• Sunray
• Zilico

[Market Driver]
• Increased Incidence of Smoking
• For a full, detailed list, view our report

[Market Challenge]
• Lack of Awareness
• For a full, detailed list, view our report

[Market Trend]
• Development of New Diagnostic Platforms
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Disease Paradigm
06.1 Epidemiology
06.2 Causes of Cervical Cancer
06.3 Diagnosis of Cervical Cancer

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08.Market Segmentation by Type of Test
08.1 Pap Smear Test
08.1.1 Conventional Pap
08.1.2 Liquid-based cytology
08.2 HPV Testing
08.3 Colposcopy
08.4 Cervical Cancer Biopsy
08.4.1 LEEP
08.4.2 ECC
08.4.3 Cone Biopsy
08.5 Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
08.6 Global HPV Testing Market
08.6.1 Market Size and Forecast
08.7 Global Colposcopy Market
08.7.1 Market Size and Forecast
08.8 Global Pap Smear Test Market
08.8.1 Market Size and Forecast
08.9 Global Cervical Cancer Biopsy Market
08.9.1 Market Size and Forecast

09.Market Segmentation by Technology
09.1 ELISA
09.2 FISH
09.3 NASBA
09.4 PCR
09.5 Multichromatic Staining and Microscopy
09.6 Optical Imaging

10.Market Segmentation by Method
10.1 Molecular Method
10.2 Cytopathological Method
10.3 Physical Method

11.Geographical Segmentation
11.1 Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market
11.2 Cervical Cancer Diagnostic Tests Market in Americas
11.2.1 Market Size and Forecast
11.3 Cervical Cancer Diagnostic Tests Market in EMEA Region
11.3.1 Market Size and Forecast
11.4 Cervical Cancer Diagnostic Tests Market in APAC Region
11.4.1 Market Size and Forecast

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and their Impact

19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors

20.Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue
20.1.4 Business Segmentation by Revenue 2011 and 2012
20.1.5 Geographical Segmentation by Revenue
20.1.6 Business Strategy
20.1.7 Key Information
20.1.8 SWOT Analysis
20.2 Becton, Dickinson and Co.
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Revenue Segmentation by Business
20.2.5 Segmental Revenue Comparison – 2013 and 2012
20.2.6 Revenue Segmentation by Geography
20.2.7 Business Strategy
20.2.8 Key Developments
20.2.9 SWOT Analysis
20.3 Hologic Inc.
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Sales by Geography
20.3.6 Business Strategy
20.3.7 Key Developments
20.3.8 SWOT Analysis
20.4 Qiagen
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Product Segmentation by Revenue 2013
20.4.4 Product Segmentation by Revenue 2012 and 2013
20.4.5 Geographical Segmentation by Revenue 2013
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
20.5 Quest Diagnostics
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation by Revenue 2013
20.5.4 Business Segmentation by Revenue 2011-2013
20.5.5 Geographical Segmentation by Revenue 2013
20.5.6 Business Strategy
20.5.7 Recent Developments
20.5.8 SWOT Analysis
20.6 Roche Diagnostics
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Business Segmentation by Revenue 2013
20.6.4 Geographical Segmentation by Revenue 2013
20.6.5 Business Strategy
20.6.6 Recent Developments

21.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Incidence of Cervical Cancer (2013-2018)
Exhibit 3: Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
Exhibit 4: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
Exhibit 5: Segmentation of Cervical Cancer Diagnostic Test Products by Type of Test
Exhibit 6: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018 (US$ million)
Exhibit 7: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018
Exhibit 8: Global HPV Testing Market 2013-2018 (US$ million)
Exhibit 9: Global Colposcopy Market 2013-2018 (US$ million)
Exhibit 10: Global Pap Smear Test Market 2013-2018 (US$ million)
Exhibit 11: Global Cervical Cancer Biopsy Market 2013-2018 (US$ million)
Exhibit 12: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Technology
Exhibit 13: Cervical Cancer Diagnostic Test Products Segmented by Technology
Exhibit 14: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Method
Exhibit 15: List of Tests Segmented Based on Methods used in Cervical Cancer Diagnostic Tests
Exhibit 16: Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
Exhibit 17: Global Cervical Cancer Diagnostic Tests Market by Geographical Segmentation 2013-2018
Exhibit 18: Cervical Cancer Diagnostic Tests Market in Americas 2013-2018 (US$ million)
Exhibit 19: Cervical Cancer Diagnostic Tests Market in EMEA Region 2013-2018 (US$ million)
Exhibit 20: Cervical Cancer Diagnostic Tests Market in APAC Region 2013-2018 (US$ million)
Exhibit 21: Advantages and Limitations of Various Diagnostic Platforms
Exhibit 22: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 23: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 24: Product Categorization of Becton, Dickinson and Co.
Exhibit 25: Revenue Segmentation of Becton, Dickinson and Co. 2013
Exhibit 26: Revenue Comparison (US$ million)
Exhibit 27: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
Exhibit 28: Revenue Segmentation of Hologic Inc. 2013
Exhibit 29: Revenue Comparison FY2012 and FY2013 (US$ million)
Exhibit 30: Hologic Inc.: Sales by Geography 2013
Exhibit 31: Qiagen: Product Segmentation by Revenue 2013
Exhibit 32: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 33: Qiagen: Geographical Segmentation by Revenue 2013
Exhibit 34: Quest Diagnostics: Business Segmentation by Revenue 2013
Exhibit 35: Quest Diagnostics: Business Segmentation by Revenue 2011-2013 (US$ billion)
Exhibit 36: Quest Diagnostics: Geographical Segmentation by Revenue 2013
Exhibit 37: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 38: Roche Diagnostics: Geographical Segmentation by Revenue 2013



【掲載企業】

Abbott Laboratories, Becton Dickinson, Hologic, Qiagen, Quest Diagnostics, Roche Diagnostics, Anthera Pharmaceuticals, Arbor Vita, Autogenomics, Biolight Meditech, BioMerieux, Biovantra, Cancer Genetics, Cervia Diagnostics, Centrel, Cooper Surgical, Cytoimmun, DySIS Medical,Edan, Femasys, Greiner Bio One, Guided Therapeutic, Incell dx, Innogenetics, Kernel Medical, Lutech Industries, Medgyn, Micromedic Technologies, Norchip, Olympus Medical, OncoHealth Corp, Optomic, Optopol Technology, Shenzhen Goldcare Meditech, Sunray, Zilico

【資料のキーワード】

子宮頸癌(Cervical Cancer)診断検査機器、パップテスト、HPVテスト、コルポスコピー検査、生検、医療機器、検査キット

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[子宮頸癌(Cervical Cancer)診断検査の世界市場] (Global Cervical Cancer Diagnostic Tests Market 2014-2018 / IRTNTR4839)販売に関する免責事項
[子宮頸癌(Cervical Cancer)診断検査の世界市場] (Global Cervical Cancer Diagnostic Tests Market 2014-2018 / IRTNTR4839)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆